Nom du produit:4-(3-bromo-4-fluorophenyl)-3-[4-(2-methylsulfanylethylamino)-1,2,5-oxadiazol-3-yl]-1,2,4-oxadiazol-5-one
IUPAC Name:4-(3-bromo-4-fluorophenyl)-3-(4-{[2-(methylsulfanyl)ethyl]amino}-1,2,5-oxadiazol-3-yl)-4,5-dihydro-1,2,4-oxadiazol-5-one
- CAS:1888341-29-4
- Formule moléculaire:C13H11BrFN5O3S
- Pureté:98%
- Numéro de catalogue:CM607293
- Poids moléculaire:416.23
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1888341-29-4
- Formule moléculaire:C13H11BrFN5O3S
- Point de fusion:-
- Code SMILES:CSCCNC1=NON=C1C1=NOC(=O)N1C1=CC(Br)=C(F)C=C1
- Densité:
- Numéro de catalogue:CM607293
- Poids moléculaire:416.23
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Furazans
- Incorporation of heterocycles into drug molecules can enhance physical properties and biological activity. Oxadiazoles are a class of five-membered heterocycles containing one oxygen and two nitrogen atoms with special biological activity and thermodynamic properties. 1,2,4- and 1,3,4-oxadiazoles are widely used in the development of bioactive molecules, but 1,2,5-oxadiazoles (furazans) are used relatively sparingly. Compared with 1,2,4- and 1,3,4-isomers, 1,2,5-oxadiazole has unique physicochemical properties and electronic effects. The furazan ring has a strong inductive effect, comparable to that of trifluoromethyl or tetrazolyl. The unique properties of furoxan can confer specific pharmacological activities to drug-like molecules.